Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iguratimod and Tofacitinib Combination in Refractory Rheumatoid Arthritis
NCT06945666Phase 4Not yet recruiting
- Start
- Aug 2025
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of iguratimod in rheumatoid arthritis (RA). Planned start Aug 2025; status: not yet recruiting.
02
Drugs
iguratimod
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT06945666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06945666.